Neuro-oncological research output in the Middle East: A scoping review

Q3 Medicine

Cancer treatment and research communications Pub Date : 2024-01-01 DOI:10.1016/j.ctarc.2025.100883

Ibraheem M. Alkhawaldeh , Mohammad Al-Jafari , Mostafa Hossam El din Moawad , Yasmeen Jamal Alabdallat , Mahmoud Shaaban Abdelgalil , Amro K. AlQurm , Sadeen Zein Eddin , Layan H. Darwish , Hamza K. Alsalhi , Safa G. Odeh , Abdulqadir J. Nashwan , Ahmad A. Abujaber

{"title":"Neuro-oncological research output in the Middle East: A scoping review","authors":"Ibraheem M. Alkhawaldeh , Mohammad Al-Jafari , Mostafa Hossam El din Moawad , Yasmeen Jamal Alabdallat , Mahmoud Shaaban Abdelgalil , Amro K. AlQurm , Sadeen Zein Eddin , Layan H. Darwish , Hamza K. Alsalhi , Safa G. Odeh , Abdulqadir J. Nashwan , Ahmad A. Abujaber","doi":"10.1016/j.ctarc.2025.100883","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>The current research efforts in the Middle East do not sufficiently capture the full extent of the burden posed by brain tumors in the region.</div></div><div><h3>Objective</h3><div>Our study aimed to investigate the present state and future prospects of neuro-oncological research in the Middle East, with a focus on addressing existing research gaps.</div></div><div><h3>Methods</h3><div>We conducted a comprehensive literature search on brain tumors in the Middle East, utilizing PubMed, Scopus, and Web of Science databases. Data extraction was performed by a team of four authors using Microsoft Excel. We categorized studies based on research type, study design, subject matter, and author collaboration. Statistical analysis was conducted using RStudio 4.2.3 for categorical variables, and charts and figures were generated using RStudio 4.2.3 and Microsoft Excel version 16.</div></div><div><h3>Results</h3><div>Our scoping review analyzed 1,451 research articles related to Central Nervous System (CNS) tumors. Primary research accounted for 65.3 % of the studies, secondary research for 11.4 %, and other research types for 23.3 %. Turkish and Iranian authors played a significant role in primary research. Case reports (23.7 %) and retrospective studies (15.9 %) were the most common study designs. Clinical studies constituted the majority (89.5 %), with public health (2.75 %) and experimental studies (7.75 %) forming the rest. Gliomas were the most prevalent CNS tumor type (20.7 %), followed by astrocytomas (6.8 %) and meningiomas (6.2 %).</div></div><div><h3>Conclusion</h3><div>To meet the increasing demands of researchers, improved access to high-quality neurosurgical programs and centers in the Middle East is essential. Inadequate institutional planning may contribute to the current research accessibility deficits.</div></div>","PeriodicalId":9507,"journal":{"name":"Cancer treatment and research communications","volume":"43 ","pages":"Article 100883"},"PeriodicalIF":0.0000,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer treatment and research communications","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2468294225000218","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Background

The current research efforts in the Middle East do not sufficiently capture the full extent of the burden posed by brain tumors in the region.

Objective

Our study aimed to investigate the present state and future prospects of neuro-oncological research in the Middle East, with a focus on addressing existing research gaps.

Methods

We conducted a comprehensive literature search on brain tumors in the Middle East, utilizing PubMed, Scopus, and Web of Science databases. Data extraction was performed by a team of four authors using Microsoft Excel. We categorized studies based on research type, study design, subject matter, and author collaboration. Statistical analysis was conducted using RStudio 4.2.3 for categorical variables, and charts and figures were generated using RStudio 4.2.3 and Microsoft Excel version 16.

Results

Our scoping review analyzed 1,451 research articles related to Central Nervous System (CNS) tumors. Primary research accounted for 65.3 % of the studies, secondary research for 11.4 %, and other research types for 23.3 %. Turkish and Iranian authors played a significant role in primary research. Case reports (23.7 %) and retrospective studies (15.9 %) were the most common study designs. Clinical studies constituted the majority (89.5 %), with public health (2.75 %) and experimental studies (7.75 %) forming the rest. Gliomas were the most prevalent CNS tumor type (20.7 %), followed by astrocytomas (6.8 %) and meningiomas (6.2 %).

Conclusion

To meet the increasing demands of researchers, improved access to high-quality neurosurgical programs and centers in the Middle East is essential. Inadequate institutional planning may contribute to the current research accessibility deficits.

查看原文本刊更多论文

中东地区的神经肿瘤研究成果：范围审查

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cancer treatment and research communications Medicine-Oncology

CiteScore

4.30

自引率

0.00%

发文量

148

审稿时长

56 days

期刊介绍： Cancer Treatment and Research Communications is an international peer-reviewed publication dedicated to providing comprehensive basic, translational, and clinical oncology research. The journal is devoted to articles on detection, diagnosis, prevention, policy, and treatment of cancer and provides a global forum for the nurturing and development of future generations of oncology scientists. Cancer Treatment and Research Communications publishes comprehensive reviews and original studies describing various aspects of basic through clinical research of all tumor types. The journal also accepts clinical studies in oncology, with an emphasis on prospective early phase clinical trials. Specific areas of interest include basic, translational, and clinical research and mechanistic approaches; cancer biology; molecular carcinogenesis; genetics and genomics; stem cell and developmental biology; immunology; molecular and cellular oncology; systems biology; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; cancer policy; and integration of various approaches. Our mission is to be the premier source of relevant information through promoting excellence in research and facilitating the timely translation of that science to health care and clinical practice.